Massachusetts start-up Synthpop has secured $2.6m in seed funding and unveiled a connected system of artificial intelligence (AI) assistants for healthcare providers.

The connected system of AI assistants is for healthcare workflow automation. The company’s customers are using its AI assistants for various tedious tasks such as data entry into complex EMR schemas, connecting patient charts to clinical guidelines and payor policies in real time, responding to denials and record requests, and providing real-time feedback and summarisation during patient visits.

The AI assistants are fine-tuned using existing medical data: this is Hipaa-compliant, and accurate out-of-the-box, eliminating the need for lengthy integrations.

“Our team has decades of experience delivering care and building healthcare solutions,” said Drew Copeland, Synthpop’s director of clinical operations. “With our deep understanding of provider needs, we were able to create effective AI that clinicians and administrators actually benefit from using. Synthpop provides much-needed relief to healthcare workers by performing tasks that are tedious and time consuming.”

Copeland has over 20 years of healthcare experience and managed Mount Sinai’s sleep medicine programme.

Jan Jannink, Synthpop CTO, added: “We developed a unique method to de-identify medical records, which enables us to fine-tune large language models without risking exposure. Privacy and security are paramount, and we make sure that our methods adhere to the strictest standards.”

Jannink is an experienced start-up founder and a lecturer at Stanford University, where he is set to teach a class on developing applications with large language models in the upcoming school year.

Jannink’s fellow co-founder CEO Elad Ferber previously co-founded Spry Health (acquired in 2021), and was the vice-president of remote patient monitoring at Zoll-Itamar until last December.

“After a decade in the healthcare space, I’ve seen first hand how difficult it is to optimise workflows in health systems,” said Ferber. “We are on a mission to change that. Using the right data to fine tune models, we are able to overcome complex barriers to efficiency. Our goal is to make our healthcare system faster, more efficient and, eventually, more patient-centric.”

This initiative was made possible with a $2.6m seed investment from Zelda Ventures, Ovo Fund, Page One Ventures, Newfund, Think+ Ventures, AI Operators Fund, Flexcap and Captra Capital.

Find out more about Synthpop at www.synthpop.ai.